Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HTLS Biotechnology
Javené, Brittany, Francetw.linkedin.com ↗
- Ownership
- Private
- Employees
- ~300
- Development stage
- Other
01
Overview
HTL Biotechnology is a commercial-stage company with over 400 million syringes of hyaluronic acid safely used since 2006[1]
- Therapeutic areas
- DermatologyRheumatologyOphthalmologyMen's Health
- Modalities
- Biopolymers (Hyaluronic Acid, Polynucleotides, DNA, Recombinant Human Collagen, Heparosan)Botulinum toxin
- Industry
- Non-Drug Biotech
02
Partnerships
Eirion Therapeutics (for botulinum manufacturing)[9]Modern Meadow (acquisition of beauty and biomedical division)[6]
Beyond the preview
Go deeper on HTLS Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HTLS Biotechnology.